Network-based characterization of drug-regulated genes, drug targets, and toxicity

被引:68
|
作者
Kotlyar, Max [1 ]
Fortney, Kristen [2 ]
Jurisica, Igor [1 ,2 ,3 ,4 ]
机构
[1] Univ Hlth Network, IBM Life Sci Discovery Ctr, Ontario Canc Inst, Campbell Family Inst Canc Res, Toronto, ON M5G 1L7, Canada
[2] Univ Toronto, Dept Med Biophys, Ontario Canc Inst, Princess Margaret Hosp, Toronto, ON M5G 2M9, Canada
[3] Univ Hlth Network, Techna Inst, Toronto, ON M5G 1L7, Canada
[4] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 3H5, Canada
基金
加拿大创新基金会;
关键词
Protein-protein interactions; Drug development; Transcription regulation; Drug cytotoxicity; PROTEIN-INTERACTION NETWORKS; PREDICTIVE TOXICOLOGY; INTERACTION DATABASE; DISEASE; DISCOVERY; CANCER; CLASSIFICATION; CYTOTOXICITY; COMBINATIONS; INFORMATION;
D O I
10.1016/j.ymeth.2012.06.003
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Proteins do not exert their effects in isolation of one another, but interact together in complex networks. In recent years, sophisticated methods have been developed to leverage protein-protein interaction (PPI) network structure to improve several stages of the drug discovery process. Network-based methods have been applied to predict drug targets, drug side effects, and new therapeutic indications. In this paper we have two aims. First, we review the past contributions of network approaches and methods to drug discovery, and discuss their limitations and possible future directions. Second, we show how past work can be generalized to gain a more complete understanding of how drugs perturb networks. Previous network-based characterizations of drug effects focused on the small number of known drug targets, i.e., direct binding partners of drugs. However, drugs affect many more genes than their targets - they can profoundly affect the cell's transcriptome. For the first time, we use networks to characterize genes that are differentially regulated by drugs. We found that drug-regulated genes differed from drug targets in terms of functional annotations, cellular localizations, and topological properties. Drug targets mainly included receptors on the plasma membrane, down-regulated genes were largely in the nucleus and were enriched for DNA binding, and genes lacking drug relationships were enriched in the extracellular region. Network topology analysis indicated several significant graph properties, including high degree and betweenness for the drug targets and drug-regulated genes, though possibly due to network biases. Topological analysis also showed that proteins of down-regulated genes appear to be frequently involved in complexes. Analyzing network distances between regulated genes, we found that genes regulated by structurally similar drugs were significantly closer than genes regulated by dissimilar drugs. Finally, network centrality of a drug's differentially regulated genes correlated significantly with drug toxicity. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:499 / 507
页数:9
相关论文
共 50 条
  • [11] Network-based prediction of drug combinations
    Cheng, Feixiong
    Kovacs, Istvan A.
    Barabasi, Albert-Laszlo
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [12] Network-based drug sensitivity prediction
    Ahmed, Khandakar Tanvir
    Park, Sunho
    Jiang, Qibing
    Yeu, Yunku
    Hwang, TaeHyun
    Zhang, Wei
    BMC MEDICAL GENOMICS, 2020, 13 (Suppl 11)
  • [13] Network-based drug repurposing for schizophrenia
    Trang T. T. Truong
    Zoe S. J. Liu
    Bruna Panizzutti
    Jee Hyun Kim
    Olivia M. Dean
    Michael Berk
    Ken Walder
    Neuropsychopharmacology, 2024, 49 : 983 - 992
  • [14] Network-Based Approaches for Drug Repositioning
    Song, Tao
    Wang, Gan
    Ding, Mao
    Rodriguez-Paton, Alfonso
    Wang, Xun
    Wang, Shudong
    MOLECULAR INFORMATICS, 2022, 41 (05)
  • [15] Relationship between drug targets and drug-signature networks: a network-based genome-wide landscape
    Chae Won Lee
    Sung Min Kim
    Soonok Sa
    Myunghee Hong
    Sang-Min Nam
    Hyun Wook Han
    BMC Medical Genomics, 16
  • [16] Network-based prediction of drug combinations
    Feixiong Cheng
    István A. Kovács
    Albert-László Barabási
    Nature Communications, 10
  • [17] Network-based drug sensitivity prediction
    Khandakar Tanvir Ahmed
    Sunho Park
    Qibing Jiang
    Yunku Yeu
    TaeHyun Hwang
    Wei Zhang
    BMC Medical Genomics, 13
  • [18] Relationship between drug targets and drug-signature networks: a network-based genome-wide landscape
    Lee, Chae Won
    Kim, Sung Min
    Sa, Soonok
    Hong, Myunghee
    Nam, Sang-Min
    Han, Hyun Wook
    BMC MEDICAL GENOMICS, 2023, 16 (01)
  • [19] Network-based drug repurposing for schizophrenia
    Truong, Trang T. T.
    Liu, Zoe S. J.
    Panizzutti, Bruna
    Kim, Jee Hyun
    Dean, Olivia M.
    Berk, Michael
    Walder, Ken
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 (06) : 983 - 992
  • [20] Toxicogenomic module associations with pathogenesis: a network-based approach to understanding drug toxicity
    J J Sutherland
    Y W Webster
    J A Willy
    G H Searfoss
    K M Goldstein
    A R Irizarry
    D G Hall
    J L Stevens
    The Pharmacogenomics Journal, 2018, 18 : 377 - 390